In October, seven unique stocks valued above Rs 100 crore were identified, each held exclusively by a single fund house, highlighting selective conviction among mutual fund managers.
Tech companies are borrowing billions for artificial intelligence. Lenders are now seeking protection against potential defaults. Derivatives trading on companies like Oracle and Meta Platforms has surged. This indicates a shift in capital markets as AI drives massive investment and borrowing. Investors are hedging their exposure to this evolving landscape.
Nifty ended higher after a late rebound driven by financials, pharma, and FMCG, supported by sentiment linked to the NDAs Bihar victory. Technical indicators suggest strength above key support levels. Analysts recommend GRSE and Thyrocare based on strong breakouts, robust volume patterns, and sustained momentum across major moving averages
Five new mutual funds and one SIF are set to open for subscription this week. Fund houses typically roll out fresh products to expand their range of offerings (Source: ACE MF and Value Research).
The Nifty is poised for direction as the Q2 earnings season ends. Six key factors will guide its movement this week. These include technical momentum, the mixed performance of Q2 results, FII flows, upcoming macro events, global market sentiment, and a potential India-US trade deal announcement. Traders should focus on stock-specific opportunities and manage risk effectively
Brazilian Vice President Geraldo Alckmin said Saturday that Brazilian exported goods to the U.S. including coffee, beef and tropical fruits would still be tariffed 40%, despite President Donald Trumps decision to remove some import taxes.
Hollywood's recent slate of dramas and comedies has failed to attract moviegoers. Despite star power and critical acclaim, films like 'After the Hunt' and 'Die My Love' have played to empty theaters. This trend exacerbates a difficult year for the industry, with overall box office numbers hitting record lows.
Just like the president who came before him, Trump is trying to sell the country on his plans to create factory jobs and lower prescription drug costs.
MAGA leader Donald Trump publicly criticised Congresswoman Marjorie Taylor Greene for breaking ranks on issues like the H-1B visa program and demanding the release of Epstein files. Greene retaliated, accusing Trump of fighting the file release and using her as an example to intimidate other Republicans.
